中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 3-O-(3',4'-di-O-acetyl-2',6'-di-O-benzyl-α-D-glucopyranosyl)-5-O-benzyl-1,2-O-isopropylidene-α-D-ribofuranoside | 264230-05-9 | C39H46O12 | 706.787 |
—— | allyl 3,4-di-O-acetyl-2,6-di-O-benzyl-α-D-glucopyranoside | 178319-07-8 | C27H32O8 | 484.546 |
—— | 3-O-[2,6-di-O-benzyl-3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-yl]-α-D-glucopyranosyl]-1,2-O-isopropylidene-α-D-ribofuranose | 295320-98-8 | C34H46O12 | 646.732 |
—— | (2"S,3"S)-5-O-benzyl-3-O-[2',6'-di-O-benzyl-3',4'-di-O-(2",3"-dimethoxybutane-2",3"-diyl)-α-D-glucopyranosyl]-1,2-O-isopropylidene-α-D-ribofuranoside | 197644-82-9 | C41H52O12 | 736.857 |
—— | allyl 2,6-di-O-benzyl-α-D-glucopyranoside | 169822-03-1 | C23H28O6 | 400.472 |
—— | 3,4-di-O-acetyl-2,6-di-O-benzyl-D-glucopyranosyl dimethyl phosphite | 264230-04-8 | C26H33O10P | 536.516 |
—— | 3,5-O-benzylidene-1,2-O-isopropylidene-α-D-xylofuranose | 31504-85-5 | C15H18O5 | 278.305 |
—— | 5-O-benzyl-1,2-O-isopropylidene-α-D-ribofuranose | 23202-83-7 | C15H20O5 | 280.321 |
—— | 5-benzyl-1,2-O-isopropylidene-α-D-xylofuranose | 23202-83-7 | C15H20O5 | 280.321 |
—— | 5-O-benzyl-3-oxo-1,2-O-isopropylidene-α-D-xylofuranose | 34311-63-2 | C15H18O5 | 278.305 |
—— | (2"S,3"S)-3-O-[2',6'-di-O-benzyl-3',4'-di-O-(2",3"-dimethoxybutane-2",3"-diyl)-α-D-glucopyranosyl]-1,2-O-isopropylidene-5-O-tert-butyldiphenylsilyl-α-D-ribofuranoside | 197644-81-8 | C50H64O12Si | 885.136 |
—— | (2'S,3'S)-ethyl 2,6-di-O-benzyl-3,4-di-O-(2',3'-dimethoxybutane-2',3'-diyl)-1-thio-β-D-glucopyranoside | 197644-80-7 | C28H38O7S | 518.672 |
1,2-O-异亚丙基-alpha-D-呋喃木糖 | 1,2-O-isopropylidene-α-D-xylose | 20031-21-4 | C8H14O5 | 190.196 |
—— | ethyl 3,4-di-O-acetyl-2,6-di-O-benzyl-1-thio-β-D-glucopyranoside | 305839-24-1 | C26H32O7S | 488.602 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | [2'-O-acetyl-3'-O-(3",4"-di-O-acetyl-2",6"-di-O-benzyl-α-D-glucopyranosyl)-5'-O-benzyl-β-D-ribofuranosyloxy]prop-3-yne | 197644-84-1 | C41H46O13 | 746.808 |
—— | 1-((3-benzyloxycarbonylamino)-propyl)-2-O-acetyl-5-O-benzyl-3-O-(3',4'-di-O-acetyl-2',6'-di-O-benzyl-α-D-glucopyranosyl)-β-D-ribofuranoside | 305839-25-2 | C49H57NO15 | 899.989 |
—— | {3-[(2R,3R,4S,5R)-4-((2R,3R,4S,5S,6R)-3-Benzyloxy-6-benzyloxymethyl-4,5-dihydroxy-tetrahydro-pyran-2-yloxy)-5-benzyloxymethyl-3-hydroxy-tetrahydro-furan-2-yloxy]-propyl}-carbamic acid benzyl ester | 305839-29-6 | C43H51NO12 | 773.877 |
—— | 2',3'',4''-tri-O-acetyl-2'',5',6''-tri-O-benzyl-3'-O-α-D-glucopyranosyl-1-β-D-ribofuranosidoimidazole | 308290-84-8 | C41H46N2O12 | 758.822 |
—— | 5-O-benzyl-1-(4-methylnaphthalenyl)-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)-β-D-ribofuranose | 403731-60-2 | C43H46O9 | 706.833 |
—— | 2-O-acetyl-5-O-benzyl-1-(4-methylanisol-2-yl)-3-O-(3,4-di-O-acetyl-2,6-di-O-benzyl-α-D-glucopyranosyl)-D-ribofuranose | 403731-56-6 | C46H52O13 | 812.911 |
—— | 2'',5',6''-tri-O-benzyl-3'-O-α-D-glucopyranosyl-1-β-D-ribofuranosidoimidazole | 308290-85-9 | C35H40N2O9 | 632.711 |
—— | 5-O-benzyl-1-(4-methylanisol-2-yl)-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)-β-D-ribofuranose | 403731-57-7 | C40H46O10 | 686.799 |
—— | 5-O-benzyl-1-(4-methylanisol-2-yl)-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)-α-D-ribofuranose | 403731-38-4 | C40H46O10 | 686.799 |
—— | 1-benzimidazolyl-2-O-acetyl-5-O-benzyl-3-O-(3,4-di-O-acetyl-2,6-di-O-benzyl-α-D-glucopyranosyl)-β-D-ribofuranose | 403731-49-7 | C45H48N2O12 | 808.882 |
—— | 5-O-benzyl-1-(2-methoxynaphthalenyl)-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)-β-D-ribofuranose | 403731-54-4 | C43H46O10 | 722.832 |
IP3R initiate most cellular Ca2+signaling. AdA is the most potent agonist of IP3R. The structural complexity of AdA makes synthesis of its analogs cumbersome. We report an easy method for generating a library of potent triazole-based analogs of AdA, triazolophostins, which are the most potent AdA analogs devoid of a nucleobase.